GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr | ₹0.41 Cr |
What is the latest Total Non-Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹0.00 Cr |
Mar2021 | ₹0.17 Cr |
Mar2020 | ₹0.41 Cr |
How is Total Non-Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | -19.60 | |
Mar2023 | ₹16 Cr | 538,266.67 | |
Mar2022 | ₹0.00 Cr | -98.21 | |
Mar2021 | ₹0.17 Cr | -59.42 | |
Mar2020 | ₹0.41 Cr | - |
Compare Total Non-Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹348.1 Cr | -1.6% | -10.2% | -14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,715.0 Cr | 0.4% | -2.6% | 36% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,460.0 Cr | -0% | 3% | 54.9% | Stock Analytics | |
CIPLA | ₹115,271.0 Cr | -0.2% | -4% | 10.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,511.0 Cr | -2.6% | -1.8% | 13.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,189.5 Cr | -0.6% | 1% | 40.8% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -1.6% |
-10.2% |
-14.1% |
SENSEX | -0.9% |
-4.3% |
3.7% |
You may also like the below Video Courses